Evidence map›Paper›PMID 42014508›Full record

ArticleNature medicine2026

The Q-MONSTAR consortium: advancing fault-tolerant quantum computing for precision oncology.

Mitsuho Imai, Riu Yamashita, Takao Fujisawa, Hiroki Sokuoka, Izumi Miki, Yasutoshi Sakamoto, Toshihiro Misumi, Borna Zandkarimi, Philipp T Ernst, Hideaki Bando and 1 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Nature medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mitsuho ImaiTranslational Research Support Office, National Cancer Center Hospital East, Kashiwa, Japan.
Riu YamashitaDivision of Translational Informatics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center Hospital East, Kashiwa, Japan.
Takao FujisawaTranslational Research Support Office, National Cancer Center Hospital East, Kashiwa, Japan.
Hiroki SokuokaTranslational Research Support Office, National Cancer Center Hospital East, Kashiwa, Japan.
Izumi MikiTranslational Research Support Office, National Cancer Center Hospital East, Kashiwa, Japan.
Yasutoshi SakamotoTranslational Research Support Office, National Cancer Center Hospital East, Kashiwa, Japan.
Toshihiro MisumiDepartment of Data Science, National Cancer Center Hospital East, Kashiwa, Japan.
Borna ZandkarimiPsiQuantum, Palo Alto, CA, USA.
Philipp T ErnstPsiQuantum, Palo Alto, CA, USA.
Hideaki BandoTranslational Research Support Office, National Cancer Center Hospital East, Kashiwa, Japan.ORCID http://orcid.org/0000-0001-5041-2765
Takayuki YoshinoDepartment of Global Oncology, National Cancer Center Hospital East, Kashiwa, Japan. tyoshino@east.ncc.go.jp.ORCID http://orcid.org/0000-0002-0489-4756

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42014508

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.